Graphical-demonstration-of-the-reduction-in-waist-circumference

In case you missed it: a summary of the BCS ’21 top 10 trials (Part II)

By Ahmed El-Medany One of the most popular sessions every year, an excellent variety of trials were presented at the 2021 BCS Annual Conference. For…

View More In case you missed it: a summary of the BCS ’21 top 10 trials (Part II)
Figure 1: Taken from Chen et al (2020). Incidence of clinically driven target lesion revascularisation (TLR), target vessel myocardial infarction (TVMI), and target lesion failure (TLF). The table shows the hazard ratio and 95% confidence interval for TLR, TVMI, and TLF in the two-stent vs provisional stent group.

In case you missed it: a summary of the BCS ’21 top 10 trials (Part I)

One of the most popular sessions every year, an excellent variety of trials were presented at the 2021 BCS Annual Conference. For those that were unable to attend, or for the sake of refreshing one’s memory, the following is a summary of all the trials presented…

View More In case you missed it: a summary of the BCS ’21 top 10 trials (Part I)
Aerobic Class

Exercise training effective in reducing ambulatory blood pressure in resistant hypertension, results from the EnRicH trial

‘These findings provide clinicians with evidence to embrace moderate-intensity aerobic exercise as a standard coadjutant therapy targeting this patient population.’ The authors state.

View More Exercise training effective in reducing ambulatory blood pressure in resistant hypertension, results from the EnRicH trial
digestive system

Efpeglenatide, a novel GLP-1 receptor agonist, reduces cardiovascular events and progression of chronic renal failure in type 2 diabetes

By Ahmed El-Medany Weekly subcutaneous injections of efpeglenatide, a novel exendin-based GLP1-RA, have been shown to reduce the risk of major adverse cardiovascular events (MACE)…

View More Efpeglenatide, a novel GLP-1 receptor agonist, reduces cardiovascular events and progression of chronic renal failure in type 2 diabetes
Deaths, thromboembolism and effective haemostasis, Total and by reversal agent

Reversal agents for DOACs – a recent meta-analysis

By Saadia Aslam Major bleeding that requires hospitalisation occurs in 2% to 3.5% of patients that take DOACs. Some of these patients may require reversal…

View More Reversal agents for DOACs – a recent meta-analysis
Cardiovascular Magnetic Resonance scans

British Society of CMR survey reveals high levels of regional variation and poor equity in access to CMR

By Ahmed El-Medany Cardiovascular magnetic resonance (CMR) is widely available and established in the United Kingdom (UK) with high scan volumes by international standards. The…

View More British Society of CMR survey reveals high levels of regional variation and poor equity in access to CMR

When detecting heart murmurs, has Artificial Intelligence surpassed the Consultant Cardiologist?

A study by Chorba et al investigate Deep learning approaches in detect heart murmurs and clinically significant valvular heart disease, using recording from digital stethoscopes.…

View More When detecting heart murmurs, has Artificial Intelligence surpassed the Consultant Cardiologist?